Prof Ananya💙 @achoud72.bsky.social (@achoud72) 's Twitter Profile
Prof Ananya💙 @achoud72.bsky.social

@achoud72

NHS consultant no private work. Equality, liberty and justice, Chair in Clinical Oncology, Christie & University of Manchester, EIC BMJ Oncology. Own views

ID: 3292167613

calendar_today25-07-2015 07:38:29

11,11K Tweet

2,2K Followers

768 Following

BMJ Oncology (@bmjoncology) 's Twitter Profile Photo

Large language models have demonstrated emergent human-like capabilities in natural language processing, leading to enthusiasm about their integration in healthcare environments. bmjoncology.bmj.com/content/4/1/e0…

John McGrane (@mcgranjo777) 's Twitter Profile Photo

🚨May is Bladder Cancer awareness month🚨 What better way to recognise this than a Simply Oncology episode with the irrepressible 💙alison birtle 🎙️We discuss peri-operative treatment and the NIAGRA trial 🎙️There is so much happening in #BladderCancer Jose C. Tapia ActionBladderCancer

🚨May is Bladder Cancer awareness month🚨
What better way to recognise this than a Simply Oncology episode with the irrepressible <a href="/AlisonBirtle/">💙alison birtle</a> 
🎙️We discuss peri-operative treatment and the NIAGRA trial
🎙️There is so much happening in #BladderCancer
<a href="/TapiaJC1/">Jose C. Tapia</a> <a href="/Actionbladderca/">ActionBladderCancer</a>
Robert Huddart💙 (@robert_huddart) 's Twitter Profile Photo

News for UK radiotherapy community. Pleased to say that thanks to Macmillan Cancer Support we have been able to establish #ctrad. We plan a proposals guidance meeting on 8.7.25 If you have a new trial idea, wish to attend please contact [email protected] to register. The Royal College of Radiologists

BMJ Oncology (@bmjoncology) 's Twitter Profile Photo

A 3-year structured exercise program initiated soon after adjuvant chemotherapy for colon cancer resulted in significantly longer disease-free survival. nejm.org/doi/full/10.10…

A 3-year structured exercise program initiated soon after adjuvant chemotherapy for colon cancer resulted in significantly longer disease-free survival. nejm.org/doi/full/10.10…
tombal (@bertrandtombal) 's Twitter Profile Photo

In PEACE-3 (EORTC 1333), the addition of 6 cycles of Ra223 to enzalutamide improves PSA response time and rates (≥90%), ALP reduction time (≥30%), and ALP normalization at 6 and 12 months. EORTC silke gillessen Andrey Soares GETUG CancerTrialsIreland 🌈 SOGUG

In PEACE-3 (EORTC 1333), the addition of 6 cycles of Ra223 to enzalutamide improves PSA response time and rates (≥90%), ALP reduction time (≥30%), and ALP normalization  at 6 and 12 months. <a href="/EORTC/">EORTC</a>  <a href="/Silke_Gillessen/">silke gillessen</a> <a href="/SoaresAndrey/">Andrey Soares</a> <a href="/GETUG_Unicancer/">GETUG</a> <a href="/cancertrials_ie/">CancerTrialsIreland 🌈</a> <a href="/sogug1/">SOGUG</a>
Nuradh Joseph (@nuradh) 's Twitter Profile Photo

Thanks so much Vedang Murthy for putting together the first ever #APCCC #SouthAsia and for including #SriLanka. It was great to meet so many colleagues from #SouthAsia #Prostatecancer #oncology Vimukthini Peiris Yasiru Malinda Priyamvada Maitre

BMJ Oncology (@bmjoncology) 's Twitter Profile Photo

Although patient-reported outcomes are collected in many thousands of patients with cancer each year, these data are often not reported or methodological issues such as missing data hamper interpretation. We need to get this right, it matters. bmjoncology.bmj.com/content/4/1/e0…

Although patient-reported outcomes are collected in many thousands of patients with cancer each year, these data are often not reported or methodological issues such as missing data hamper interpretation. We need to get this right, it matters. bmjoncology.bmj.com/content/4/1/e0…
Dr. Jason Efstathiou (@drjefstathiou) 's Twitter Profile Photo

After 39 years Mass General Brigham and now his last day in clinic, wishing a happy retirement to my very dear one-of-a-kind colleague Dr. Anthony Zietman! Like a finely tuned proton, he has brought positive energy to everything-- from clinic to journal pages, to society leadership

After 39 years <a href="/MassGenBrigham/">Mass General Brigham</a> and now his last day in clinic, wishing a happy retirement to my very dear one-of-a-kind colleague Dr. Anthony Zietman! Like a finely tuned proton, he has brought positive energy to everything-- from clinic to journal pages, to society leadership
IBCN (@ibcn1997) 's Twitter Profile Photo

We are proud to launch the IBCN Exchange Grant, supporting early-career researchers in bladder cancer through international, short-term, research exchanges within the IBCN community. For more info and details or to become an IBCN member please visit: ibcnweb.com

We are proud to launch the IBCN Exchange Grant, supporting early-career researchers in bladder cancer through international, short-term, research exchanges within the IBCN community. For more info and details or to become an IBCN member please visit: ibcnweb.com
BMJ Oncology (@bmjoncology) 's Twitter Profile Photo

Patients receiving single agent adjuvant trastuzumab for early HER2 positive breast cancer at low risk of recurrence could receive 6 months rather than 12 months treatment. bmjoncology.bmj.com/content/4/1/e0…

Patients receiving single agent adjuvant trastuzumab for early HER2 positive breast cancer at low risk of recurrence could receive 6 months rather than 12 months treatment. bmjoncology.bmj.com/content/4/1/e0…
Paul Sargos (@paulsargos) 's Twitter Profile Photo

✨ JUST OUT in EUO, New paper challenging a dogma. ⏩ MUST READ: Huck constance has done a great job to show that CIS is not always a contra-indication for Trimodal Therapy in the management of MIBC. 🙏Thanks to all co-authors for their input! sciencedirect.com/science/articl…

✨ JUST OUT in EUO,
 New paper challenging a dogma.

⏩ MUST READ:
<a href="/ConstanceHuck/">Huck constance</a> has done a great job to show that CIS is not always a contra-indication for Trimodal Therapy in the management of MIBC. 

🙏Thanks to all co-authors for their input! 

sciencedirect.com/science/articl…
Mirrors of Medicine (@mirrorsmed) 's Twitter Profile Photo

INVITATION: Join us for the 2025 edition of the Global forum on GU Oncology! Register here👉 tinyurl.com/bdf4fw7y 3⃣ Meetings covering 3 disease areas: Renal, Bladder and Prostate Cancer 👥 Clinical case-based 🔁 Interactive sessions with voting and Q&A 🌐 International,

INVITATION: Join us for the 2025 edition of the Global forum on GU Oncology!
Register here👉 tinyurl.com/bdf4fw7y

3⃣ Meetings covering 3 disease areas: Renal, Bladder and Prostate Cancer
👥 Clinical case-based
🔁 Interactive sessions with voting and Q&amp;A
🌐 International,